The histone demethylase KDM6B preserves adipogenic balance by restraining hypermetabolic LYVE1+ perivascular macrophages

White adipose tissue expandability protects against metabolic disease, yet the epigenetic programmes that maintain the macrophage states supporting this adaptation remain poorly defined. Here we show that the H3K27 demethylase KDM6B sustains LYVE1 + adipose tissue perivascular macrophages (PVMs) during diet-induced white adipose tissue expansion, thereby maintaining adipogenic balance. In humans, KDM6B expression in adipose tissue macrophages associates with insulin sensitivity, glycaemic control and reduced inflammation. In mice, myeloid Kdm6b deletion reprogrammes septal and capsular LYVE1 + macrophages towards a CLEC1A + hypermetabolic perivascular state, leading to defective adipogenesis, adipocyte hypertrophy, vascular rarefaction, inflammation and impaired glucose homeostasis. Mechanistically, KDM6B limits H3K27me3 deposition at the Bmp2 locus to maintain macrophage-derived BMP2 signalling to adipose progenitors. Myeloid Bmp2 deletion partially recapitulates Kdm6b -deficient adipose dysfunction, whereas recombinant BMP2 promotes homeostatic tissue remodelling. Collectively, KDM6B acts as an epigenetic switch controlling the metabolic fate of LYVE1 + PVMs, maintaining the balance between adipogenesis-supportive and metabolic PVM states that determine adipose tissue expandability and metabolic homeostasis.

Authors

Institutions

Publication Details

Journal
Nature Metabolism
Published
2026-11-19
DOI
https://doi.org/10.1038/s42255-026-01639-0
Citations
1
Primary Topic
Adipokines, Inflammation, and Metabolic Diseases
Type
article
Field-Weighted Citation Impact
2.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The histone demethylase KDM6B preserves adipogenic balance by restraining hypermetabolic LYVE1+ perivascular macrophages

Wilfried Le Goff, Amine Toubal, Nicolas Venteclef, Patricia Legoix et al.
1 citations
Nature Metabolism
Adipokines, Inflammation, and Metabolic Diseases
2.70
article

The histone demethylase KDM6B preserves adipogenic balance by restraining hypermetabolic LYVE1+ perivascular macrophages

Wilfried Le Goff, Amine Toubal, Nicolas Venteclef, Patricia Legoix, B. Aznar, Ivan Nemazanyy, Wan Ting Kong, Daniel Lindén, Jean‐Baptiste Julla, Gilberto Velho, Florent Ginhoux, Jean–François Gautier, Marc Diedisheim, Zaineb Mezdari, Raphaëlle Ballaire, Svetoslav Chakarov, Eckardt Treuter, Antoine Soprani, Dina Chokr
article en
1 citations

Abstract

White adipose tissue expandability protects against metabolic disease, yet the epigenetic programmes that maintain the macrophage states supporting this adaptation remain poorly defined. Here we show that the H3K27 demethylase KDM6B sustains LYVE1 + adipose tissue perivascular macrophages (PVMs) during diet-induced white adipose tissue expansion, thereby maintaining adipogenic balance. In humans, KDM6B expression in adipose tissue macrophages associates with insulin sensitivity, glycaemic control and reduced inflammation. In mice, myeloid Kdm6b deletion reprogrammes septal and capsular LYVE1 + macrophages towards a CLEC1A + hypermetabolic perivascular state, leading to defective adipogenesis, adipocyte hypertrophy, vascular rarefaction, inflammation and impaired glucose homeostasis. Mechanistically, KDM6B limits H3K27me3 deposition at the Bmp2 locus to maintain macrophage-derived BMP2 signalling to adipose progenitors. Myeloid Bmp2 deletion partially recapitulates Kdm6b -deficient adipose dysfunction, whereas recombinant BMP2 promotes homeostatic tissue remodelling. Collectively, KDM6B acts as an epigenetic switch controlling the metabolic fate of LYVE1 + PVMs, maintaining the balance between adipogenesis-supportive and metabolic PVM states that determine adipose tissue expandability and metabolic homeostasis.

Nature MetabolismVol. 8(11)
AstraZeneca (United Kingdom) (GB), Centre National de la Recherche Scientifique (FR), Inserm (FR), Shanghai Jiao Tong University (CN), Université Paris Cité (FR), Institut Gustave Roussy (FR), Karolinska Institutet (SE), Sorbonne Université (FR), Institut Necker Enfants Malades (FR), Centre de Recherche des Cordeliers (FR), Institut Cochin (FR), Unité de recherche sur les maladies cardiovasculaires et métaboliques (FR), Fondation pour l’innovation en Cadiométabolisme et Nutrition (FR), Générale de Santé (FR), Structure fédérative de recherche Necker (FR), Shanghai Institute of Immunology (CN), Institut Curie (FR)
Laboratoire d'Excellence Inflamex, Fondation Francophone pour la Recherche sur le Diabète, European Commission, European Foundation for the Study of Diabetes, Agence Nationale de la Recherche, Cancerfonden, Fondation pour la Recherche Médicale, Karolinska Institutet, Novo Nordisk, Vetenskapsrådet, Novo Nordisk Fonden, National Institutes of Health, Horizon 2020 Framework Programme, Center for Innovative Medicine, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 16%
Adipokines, Inflammation, and Metabolic Diseases
2.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon